Interbreed variation in serum serotonin (5-hydroxytryptamine) concentration in healthy dogs.

[en] INTRODUCTION: Serotonin (5-hydroxytryptamine [5-HT]) has several biological functions. In different species, excessive 5-HT has been linked to valvular lesions, similar to those seen in dogs with myxomatous mitral valve disease. Previous studies suggest higher 5-HT in healthy Cavalier King Charles Spaniels (CKCSs), a breed highly affected by myxomatous mitral valve disease, compared to other breeds. OBJECTIVE: To investigate potential interbreed variation in serum 5-HT in healthy dogs. ANIMALS: 483 healthy dogs of nine breeds aged 1-7 years. METHODS: Dogs were examined at five European centers. Absence of cardiovascular, organ-related, or systemic diseases was ensured by thorough clinical investigations including echocardiography. Serum was frozen and later analyzed by enzyme-linked immunosorbent assay (ELISA). RESULTS: Median 5-HT concentration was 252.5 (interquartile range = 145.5-390.6) ng/mL. Overall breed difference was found (p<0.0001), and 42% of pairwise breed comparisons were significant. Univariate regression analysis showed association between serum 5-HT concentration and breed, center of examination, storage time, and sex, with higher 5-HT in females. In multiple regression analysis, the final model had an adjusted R2 of 0.27 with breed (p<0.0001), center (p<0.0001), and storage time (p=0.014) remaining significant. Within centers, overall breed differences were found at 3/5 centers (p≤0.028), and pairwise comparisons within those centers showed breed differences in 42% of comparisons. Among the included breeds, Newfoundlands, Belgian Shepherds and CKCSs had highest 5-HT concentrations. CONCLUSIONS: Interbreed variation in serum 5-HT concentration was found in healthy dogs aged 1-7 years. These differences should be taken into account when designing clinical studies.

Disciplines :

Veterinary medicine & animal health

Author, co-author :

Höglund, Katja

Häggström, Jens

Hanas, S

Merveille, Anne-Christine ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux

Gouni, Vassiliki

Wiberg, Maria

Lundgren Willesen, Jacob

Mc Entee, Kathleen ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux

Mejer Sorensen, Louise

Tiret, Laurent

More authors (6 more)

Language :

English

Title :

Interbreed variation in serum serotonin (5-hydroxytryptamine) concentration in healthy dogs.

Publication date :

June 2018

Journal title :

Journal of Veterinary Cardiology

ISSN :

1760-2734

eISSN :

1875-0834

Publisher :

Elsevier, Netherlands

Peer reviewed :

Peer reviewed

European Projects :

FP7 - 201370 - LUPA - Unravelling the molecular basis of common complex human disorders using the dog as a model system

Funders :

CE - Commission Européenne [BE]

Available on ORBi :

since 07 August 2018

Statistics

Number of views

72 (4 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Bellivier, F., Leboyer, M., Courtet, P., Buresi, C., Beaufils, B., Samolyk, D., Allilaire, J.F., Feingold, J., Mallet, J., Malafosse, A., Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 55 (1998), 33–37.
Jonnakuty, C., Gragnoli, C., What do we know about serotonin?. J Cell Physiol 217 (2008), 301–306.
Ramage, A.G., Villalon, C.M., 5-hydroxytryptamine and cardiovascular regulation. Trends Pharmacol Sci 29 (2008), 472–481.
Namkung, J., Kim, H., Park, S., Peripheral serotonin: a new player in systemic energy homeostasis. Mol Cells 38 (2015), 1023–1028.
Ursin, R., Serotonin and sleep. Sleep Med Rev 6 (2002), 55–69.
Fligny, C., Fromes, Y., Bonnin, P., Darmon, M., Bayard, E., Launay, J.M., Cote, F., Mallet, J., Vodjdani, G., Maternal serotonin influences cardiac function in adult offspring. FASEB J 22 (2008), 2340–2349.
Buskohl, P.R., Sun, M.J., Thompson, R.P., Butcher, J.T., Serotonin potentiates transforming growth factor-beta3 induced biomechanical remodeling in avian embryonic atrioventricular valves. PLoS One, 7, 2012, e42527.
Pavone, L.M., Norris, R.A., Distinct signaling pathways activated by “extracellular” and “intracellular” serotonin in heart valve development and disease. Cell Biochem Biophys 67 (2013), 819–828.
Cote, F., Thevenot, E., Fligny, C., Fromes, Y., Darmon, M., Ripoche, M.A., Bayard, E., Hanoun, N., Saurini, F., Lechat, P., Dandolo, L., Hamon, M., Mallet, J., Vodjdani, G., Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci U S A 100 (2003), 13525–13530.
Disatian, S., Orton, E.C., Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease. J Heart Valve Dis 18 (2009), 44–51.
Oyama, M.A., Chittur, S.V., Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease. Am J Vet Res 67 (2006), 1307–1318.
Arndt, J.W., Reynolds, C.A., Singletary, G.E., Connolly, J.M., Levy, R.J., Oyama, M.A., Serum serotonin concentrations in dogs with degenerative mitral valve disease. J Vet Intern Med 23 (2009), 1208–1213.
Cremer, S.E., Singletary, G.E., Olsen, L.H., Wallace, K., Häggström, J., Ljungvall, I., Höglund, K., Reynolds, C.A., Pizzinat, N., Oyama, M.A., Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease. J Vet Intern Med 28 (2014), 1534–1540.
Lacerda, C.M., Maclea, H.B., Kisiday, J.D., Orton, E.C., Static and cyclic tensile strain induce myxomatous effector proteins and serotonin in canine mitral valves. J Vet Cardiol 14 (2012), 223–230.
Ljungvall, I., Höglund, K., Lilliehook, I., Oyama, M.A., Tidholm, A., Tvedten, H., Häggström, J., Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs. J Vet Intern Med 27 (2013), 1105–1112.
Cremer, S.E., Kristensen, A.T., Reimann, M.J., Eriksen, N.B., Petersen, S.F., Marschner, C.B., Tarnow, I., Oyama, M.A., Olsen, L.H., Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease. Am J Vet Res 76 (2015), 520–531.
Mangklabruks, T., Surachetpong, S.D., Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease. J Vet Cardiol 16 (2014), 155–162.
Anderson, G.M., Stevenson, J.M., Cohen, D.J., Steady-state model for plasma free and platelet serotonin in man. Life Sci 41 (1987), 1777–1785.
Connolly, H.M., Crary, J.L., McGoon, M.D., Hensrud, D.D., Edwards, B.S., Edwards, W.D., Schaff, H.V., Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337 (1997), 581–588.
Pritchett, A.M., Morrison, J.F., Edwards, W.D., Schaff, H.V., Connolly, H.M., Espinosa, R.E., Valvular heart disease in patients taking pergolide. Mayo Clin Proc 77 (2002), 1280–1286.
Gustafsson, B.I., Tommeras, K., Nordrum, I., Loennechen, J.P., Brunsvik, A., Solligard, E., Fossmark, R., Bakke, I., Syversen, U., Waldum, H., Long-term serotonin administration induces heart valve disease in rats. Circulation 111 (2005), 1517–1522.
Elangbam, C.S., Job, L.E., Zadrozny, L.M., Barton, J.C., Yoon, L.W., Gates, L.D., Slocum, N., 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats. Exp Toxicol Pathol 60 (2008), 253–262.
Häggström, J., Hansson, K., Kvart, C., Swenson, L., Chronic valvular disease in the cavalier King Charles spaniel in Sweden. Vet Rec 131 (1992), 549–553.
Roels, E., Krafft, E., Antoine, N., Farnir, F., Laurila, H.P., Holopainen, S., Rajamaki, M.M., Clercx, C., Evaluation of chemokines CXCL8 and CCL2, serotonin, and vascular endothelial growth factor serum concentrations in healthy dogs from seven breeds with variable predisposition for canine idiopathic pulmonary fibrosis. Res Vet Sci 101 (2015), 57–62.
Lequarre, A.S., Andersson, L., Andre, C., Fredholm, M., Hitte, C., Leeb, T., Lohi, H., Lindblad-Toh, K., Georges, M., LUPA: A European initiative taking advantage of the canine genome architecture for unravelling complex disorders in both human and dogs. Vet J 189 (2011), 155–159.
Laflamme, D.P., Development and validation of a body condition score system for dogs: a clinical tool. Canine Pract 22 (1997), 10–15.
Brown, S., Atkins, C., Bagley, R., Carr, A., Cowgill, L., Davidson, M., Egner, B., Elliott, J., Henik, R., Labato, M., Littman, M., Polzin, D., Ross, L., Snyder, P., Stepien, R., Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 21 (2007), 542–558.
Thomas, W.P., Gaber, C.E., Jacobs, G.J., Kaplan, P.M., Lombard, C.W., Moise, N.S., Moses, B.L., Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 7 (1993), 247–252.
Forsberg, S.K., Kierczak, M., Ljungvall, I., Merveille, A.C., Gouni, V., Wiberg, M., Lundgren Willesen, J., Hanas, S., Lequarre, A.S., Mejer Sorensen, L., Tiret, L., McEntee, K., Seppala, E., Koch, J., Battaille, G., Lohi, H., Fredholm, M., Chetboul, V., Haggstrom, J., Carlborg, O., Lindblad-Toh, K., Höglund, K., The shepherds’ tale: a genome-wide study across 9 dog breeds Implicates two loci in the regulation of fructosamine serum concentration in belgian shepherds. PLoS One, 10, 2015, e0123173.
Höglund, K., Lequarre, A.S., Ljungvall, I., Mc Entee, K., Merveille, A.C., Wiberg, M., Gouni, V., Lundgren Willesen, J., Hanas, S., Wess, G., Mejer Sorensen, L., Tiret, L., Kierczak, M., Forsberg, S.K., Seppala, E., Lindblad-Toh, K., Lohi, H., Chetboul, V., Fredholm, M., Häggström, J., Effect of breed on plasma Endothelin-1 concentration, plasma renin activity, and serum cortisol concentration in healthy dogs. J Vet Intern Med 30 (2016), 566–573.
Bland, M., Multifactorial methods. Bland, M., (eds.) An introduction to medical statistics, 2nd ed., 1995, Oxford University Press, Oxford, 322–323.
Thrusfield, M.V., Aitken, C.G.G., Darke, P.G.G., Observations on breed and sex in relation to canine heart-valve incompetence. J Small Anim Pract 26 (1985), 709–717.
Parker, H.G., Ostrander, E.A., Canine genomics and genetics: running with the pack. PLoS Genet, 1, 2005, e58.
Sjöstrand, K., Wess, G., Ljungvall, I., Häggström, J., Merveille, A.C., Wiberg, M., Gouni, V., Lundgren Willesen, J., Hanås, S., Lequarre, A.S., Mejer Sorensen, L., Wolf, J., Tiret, L., Kierczak, M., Forsberg, S., McEntee, K., Battaille, G., Seppala, E., Lindblad-Toh, K., Georges, M., Lohi, H., Chetboul, V., Fredholm, M., Höglund, K., Breed differences in natriuretic peptides in healthy dogs. J Vet Intern Med 28 (2014), 451–457.
Höglund, K., Hanås, S., Carnabuci, C., Ljungvall, I., Tidholm, A., Häggström, J., Blood pressure, heart rate, and urinary catecholamines in healthy dogs subjected to different clinical settings. J Vet Intern Med 26 (2012), 1300–1308.
Firdova, Z., Turnova, E., Bielikova, M., Turna, J., Dudas, A., The prevalence of ABCB1:c.227_230delATAG mutation in affected dog breeds from European countries. Res Vet Sci 106 (2016), 89–92.
Chauveau, J., Fert, V., Morel, A.M., Delaage, M.A., Rapid and specific enzyme immunoassay of serotonin. Clin Chem 37 (1991), 1178–1184.
Hindberg, I., Naesh, O., Serotonin concentrations in plasma and variations during the menstrual cycle. Clin Chem 38 (1992), 2087–2089.
Madsen, M.B., Olsen, L.H., Häggström, J., Höglund, K., Ljungvall, I., Falk, T., Wess, G., Stephenson, H., Dukes-McEwan, J., Chetboul, V., Gouni, V., Proschowsky, H.F., Cirera, S., Karlskov-Mortensen, P., Fredholm, M., Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels. J Hered 102:Suppl 1 (2011), S62–S67.
Olsen, L.H., Fredholm, M., Pedersen, H.D., Epidemiology and inheritance of mitral valve prolapse in Dachshunds. J Vet Intern Med 13 (1999), 448–456.
Trofimova, I., Robbins, T.W., Temperament and arousal systems: a new synthesis of differential psychology and functional neurochemistry. Neurosci Biobehav Rev 64 (2016), 382–402.
Ni, W., Watts, S.W., 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol 33 (2006), 575–583.
Muck-Seler, D., Pivac, N., Sagud, M., Jakovljevic, M., Mihaljevic-Peles, A., The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 26 (2002), 1235–1243.
León, M., Rosado, B., García-Belenguer, S., Chacón, G., Villegas, A., Palacio, J., Assessment of serotonin in serum, plasma, and platelets of aggressive dogs. J Vet Behav 7 (2012), 348–352.
Yabanoglu, S., Akkiki, M., Seguelas, M.H., Mialet-Perez, J., Parini, A., Pizzinat, N., Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol 46 (2009), 518–525.
Oyama, M.A., Levy, R.J., Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease. J Vet Intern Med 24 (2010), 27–36.
Tanaka, R., Yamane, Y., Platelet aggregation in dogs with mitral valve regurgitation. Am J Vet Res 61 (2000), 1248–1251.
Olsen, L.H., Kristensen, A.T., Haggstrom, J., Jensen, A.L., Klitgaard, B., Hansson, H., Pedersen, H.D., Increased platelet aggregation response in cavalier king charles spaniels with mitral valve prolapse. J Vet Intern Med 15 (2001), 209–216.
Ikeda, K., Tojo, K., Otsubo, C., Udagawa, T., Kumazawa, K., Ishikawa, M., Tokudome, G., Hosoya, T., Tajima, N., Claycomb, W.C., Nakao, K., Kawamura, M., 5-hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes. Biochem Biophys Res Commun 328 (2005), 522–525.
Cote, F., Fligny, C., Fromes, Y., Mallet, J., Vodjdani, G., Recent advances in understanding serotonin regulation of cardiovascular function. Trends Mol Med 10 (2004), 232–238.
Disatian, S., Lacerda, C., Orton, E.C., Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves. J Heart Valve Dis 19 (2010), 71–78.